ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer

Journal:

The New England Journal of Medicine

Published:

2025-10-21

DOI:

10.1056/nejmoa2511885

Affiliations:

30

Authors:

31

Go to article

Institutions	Authors	Share
Genentech, Inc., United States of America (USA)	4.500000	0.15
Hospital of Santa Maria Terni, Italy	1.500000	0.05
IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), Italy	1.000000	0.03
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Spain	1.000000	0.03
Technical University of Munich (TUM), Germany	1.000000	0.03
CHU de Bordeaux, France	1.000000	0.03
IRCCS Istituto Oncologico Veneto (IOV), Italy	1.000000	0.03
Ankara University, Turkey	1.000000	0.03
Seoul National University Hospital (SNUH), South Korea	1.000000	0.03
Hospital Universitario 12 de Octubre, Spain	1.000000	0.03
Samsung Medical Center (SMC), South Korea	1.000000	0.03
Hunan Cancer Hospital, China	1.000000	0.03
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.03
University Clinical Hospital, Wroclaw Medical University, Poland	1.000000	0.03
La Paz University Hospital, UAM, Spain	1.000000	0.03
Aarhus University (AU), Denmark	1.000000	0.03
Istinye University (ISU), Turkey	1.000000	0.03
Fudan University Shanghai Cancer Center (FUSCC), China	1.000000	0.03
University of Tsukuba, Japan	1.000000	0.03
NIHR Barts Biomedical Research Centre (BRC), United Kingdom (UK)	1.000000	0.03
Asan Medical Center (AMC), South Korea	1.000000	0.03
Vall d'Hebron University Hospital (HUVH), ICS, Spain	1.000000	0.03
Centro de Pesquisas Oncológicas (CEPON), Brazil	1.000000	0.03
Hospital Alemão Oswaldo Cruz, Brazil	1.000000	0.03
Agostino Gemelli University Polyclinic, Italy	0.500000	0.02
IRCCS San Raffaele Hospital (HSR), Italy	0.500000	0.02
World Bladder Cancer Patient Coalition, Belgium	0.500000	0.02
Fight Bladder Cancer, United Kingdom (UK)	0.500000	0.02
Vita-Salute San Raffaele University (UniSR), Italy	0.500000	0.02
Catholic University of the Sacred Heart (UCSC), Italy	0.500000	0.02

Interested in Oncology and Carcinogenesis?